Login / Signup

Can Pyridoxine Successfully Reduce Behavioral Side Effects from Levetiracetam? A Critically Appraised Topic.

Nikita ChhabraAimen VanoodMatthew T HoerthCristina Valencia SanchezCumara B O'Carroll
Published in: The neurologist (2023)
This study suggests that pyridoxine for the treatment of levetiracetam-induced behavioral side effects may result in modest improvement, although many limitations prevent conclusive results. There remains a need for a double-blinded, randomized control trial in both the adult and pediatric populations.
Keyphrases
  • open label
  • double blind
  • phase iii
  • young adults
  • combination therapy